We examined messenger ribonucleic acid (mRNA) expression levels of IL-8 as a neutrophil-related marker [15] and eotaxin-2/CCL24 as an eosinophil-related marker [16] for DIOSD in patients with atopic dermatitis undergoing treatment with dupilumab. The gene discussed is CCL24; the disease is atopic eczema.